Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.230
+0.030 (2.50%)
Aug 4, 2026, 4:00 PM EDT - Market closed
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $88.93 million as of August 4, 2026. Its market cap has decreased by -0.67% in one year.
Market Cap
88.93M
Enterprise Value
45.47M
1-Year Change
-0.67%
Ranking
Category
Stock Price
$1.23
ChartMarket Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $88.93M, a decrease of -81.82%. That is a compound annual growth rate of -27.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 88.93M | 1.43% |
| Dec 31, 2025 | 87.67M | -37.65% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Verrica Pharmaceuticals | 92.42M |
| Aldeyra Therapeutics | 91.69M |
| NeOnc Technologies Holdings | 90.77M |
| Fortress Biotech | 90.02M |
| OKYO Pharma | 88.43M |
| PolyPid | 86.95M |
| Cognition Therapeutics | 86.65M |
| Gossamer Bio | 85.55M |